Lantern Pharma Inc
(LTRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,524 | 54,669 | 61,354 | 81,374 | 19,229 |
| Marketable Securities | 19,201 | 19,164 | 18,235 | N/A | N/A |
| TOTAL | $72,716 | $76,337 | $82,131 | $82,485 | $20,237 |
| Non-Current Assets | |||||
| PPE Net | 30 | 32 | 31 | 20 | 22 |
| Other Non-Current Assets | 1,204 | 1,237 | 270 | 0 | 101 |
| TOTAL | $1,234 | $1,270 | $301 | $20 | $123 |
| Total Assets | $73,951 | $77,606 | $82,432 | $82,505 | $20,360 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,174 | 1,637 | 2,542 | 665 | 552 |
| TOTAL | $2,326 | $1,786 | $2,688 | $665 | $552 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 109 | 109 |
| Other Non-Current Liabilities | 53 | 92 | 131 | 0 | 0 |
| TOTAL | $53 | $92 | $131 | $109 | $109 |
| Total Liabilities | $2,379 | $1,878 | $2,819 | $773 | $661 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,780 | 11,188 | 11,184 | 11,181 | 11,170 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -25,023 | -21,483 | -17,429 | -15,112 | -12,660 |
| Other shareholders' equity | -93 | -103 | -48 | 0 | 0 |
| TOTAL | $71,571 | $75,729 | $79,613 | $81,732 | $19,699 |
| Total Liabilities And Equity | $73,951 | $77,606 | $82,432 | $82,505 | $20,360 |